p210 Bcr–Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia (original) (raw)

Oncogene volume 17, pages 667–672 (1998)Cite this article

Abstract

Chronic myeloid leukaemia (CML) is a clonal disorder of the pluripotent haemopoietic stem cell, the hallmark of which is the constitutively activated Bcr–Abl protein tyrosine kinase. During the initial chronic phase of CML the primitive multipotent leukaemic progenitor cells remain growth factor dependant and are capable of producing terminally differentiated cells. Although the available evidence suggests that Bcr–Abl directly affects signalling pathways involved in controlling the development of primitive haemopoietic progenitors the identification of the specific biological consequences of Bcr–Abl activity in these progenitors has been hampered by the lack of suitable systems modelling CML. By transfecting the multipotent haemopoietic cell line FDCP-Mix with a temperature sensitive mutant of Bcr–Abl we have developed the first working model that mirrors the chronic phase of CML. FDCP-Mix cells expressing Bcr–Abl tyrosine kinase activity remain growth factor dependent and retain their ability to differentiate. Normal neutrophilic cells are formed in response to G-CSF and GM-CSF. In addition, the transfected FDCP-Mix cells grown at the permissive temperature for Bcr–Abl tyrosine kinase activity display enhanced survival and proliferation in low concentrations of growth factor. These findings are consistent with the initial subtle changes seen in CML progenitor cells during the chronic phase and confirm that Bcr–Abl effects are context specific, i.e. they depend on the origin and developmental potential of the transfected cells. This questions the significance of studies in non-haemopoietic and differentiation blocked haemopoietic cells.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 50 print issues and online access

$259.00 per year

only $5.18 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Leukaemia Research Fund Cellular Development Unit, UMIST, Sackville Street, Manchester, M60 1QD
    Andrew Pierce, P Jane Owen-Lynch & Anthony D Whetton
  2. Department of Biomolecular Sciences, UMIST, Sackville Street, Manchester, M60 1QD
    Elaine Spooncer
  3. Department of Experimental Haematology, Cancer Research Campaign, Paterson Institute for Cancer Research, Christie Hospital, NHS Trust, Manchester, M20 9BX, UK
    Elaine Spooncer & T Michael Dexter

Authors

  1. Andrew Pierce
    You can also search for this author inPubMed Google Scholar
  2. P Jane Owen-Lynch
    You can also search for this author inPubMed Google Scholar
  3. Elaine Spooncer
    You can also search for this author inPubMed Google Scholar
  4. T Michael Dexter
    You can also search for this author inPubMed Google Scholar
  5. Anthony D Whetton
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Pierce, A., Owen-Lynch, P., Spooncer, E. et al. p210 Bcr–Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.Oncogene 17, 667–672 (1998). https://doi.org/10.1038/sj.onc.1201969

Download citation

Keywords

This article is cited by